Related Experiment Videos
Insights
Hepatitis B virus (HBV) primarily infects infants through maternal transmission, with acute maternal hepatitis posing a higher risk than carrier mothers. Prophylaxis strategies for newborns require further investigation.
Area of Science:
- Hepatology
- Virology
- Pediatrics
Background:
- Hepatitis B virus (HBV) causes diverse infant diseases, often presenting as asymptomatic carriers.
- Maternal-infant transmission is the predominant route of HBV infection in newborns.
- While blood product transfusion was a concern, it is now less significant.
Purpose of the Study:
- To analyze the transmission dynamics of Hepatitis B virus (HBV) from mothers to infants.
- To identify risk factors associated with HBV transmission during pregnancy and childbirth.
- To evaluate the effectiveness of current and potential prophylactic measures.
Main Methods:
- Review of existing literature on HBV transmission patterns.
- Analysis of infant infection rates based on maternal HBV status (carrier vs. acute hepatitis).
- Comparison of transmission efficiency related to specific HBV markers (e-antigen, DNA polymerase, anti-e).
Main Results:
- Acute maternal hepatitis during the perinatal period leads to higher infant infection rates than carrier mothers.
- Carrier mothers positive for e-antigen or HBV-associated DNA polymerase exhibit higher transmission rates.
- Intrapartum and postpartum transmission are more common than transplacental infection; maternal anti-e may offer protection.
Conclusions:
- Maternal-infant transmission is the primary driver of HBV infection in infants.
- Understanding maternal HBV status and viral markers is crucial for risk assessment.
- Further evaluation of newborn prophylaxis, such as immune serum globulin, is warranted.
Abstract:
HBV has been shown to be responsible for a broad spectrum of disease in infants although most are asymptomatic carriers with mild transaminase elevation and unresolved hepatitis on liver biopsy. Maternal-infant transmission is responsible for most infections. Blood product infusion should become less significant. Acute maternal hepatitis in the perinatal period results in asymptomatic infant infections at rates far exceeding transmission from asymptomatic carrier mothers. Carrier mothers with the e-antigen or HBV-associated DNA polymerase transmit infection more readily than do carrier mothers without these HBV markers. The presence of maternal anti-e may be protective. Intrapartum and postpartum transmission occurs more often than transplacental infection. For this reason attempts at prophylaxis with immune serum globulin administered in the newborn period should be further evaluated.